IQVIA (IQV) is a publicly traded Healthcare sector company. As of May 20, 2026, IQV trades at $169.28 with a market cap of $28.84B and a P/E ratio of 20.97. IQV moved -0.93% today. Year to date, IQV is -26.89%; over the trailing twelve months it is +18.32%. Its 52-week range spans $134.65 to $247.05. Analyst consensus is strong buy with an average price target of $215.90. Rallies surfaces IQV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading IQV stock inside the company?
Recent IQV insider activity includes BOUSBIB ARI sold 36.56K, Sherbet Eric sold 4.00K, BOUSBIB ARI sold 800, BOUSBIB ARI sold 7.32K, and BOUSBIB ARI sold 13.74K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
IQV Key Metrics
Key financial metrics for IQV
Metric
Value
Price
$169.28
Market Cap
$28.84B
P/E Ratio
20.97
EPS
$8.13
Dividend Yield
0.00%
52-Week High
$247.05
52-Week Low
$134.65
Volume
1.92M
Avg Volume
0
Revenue (TTM)
$16.63B
Net Income
$1.39B
Gross Margin
0.00%
Recent IQV Insider Trades
BOUSBIB ARI sold 36.56K (~$8.13M) on Dec 18, 2025.
Sherbet Eric sold 4.00K (~$878.80K) on Oct 29, 2025.
BOUSBIB ARI sold 800 (~$174.06K) on Oct 29, 2025.
BOUSBIB ARI sold 7.32K (~$1.60M) on Oct 29, 2025.
BOUSBIB ARI sold 13.74K (~$3.01M) on Oct 29, 2025.
Recent IQV insider activity includes BOUSBIB ARI sold 36.56K, Sherbet Eric sold 4.00K, BOUSBIB ARI sold 800, BOUSBIB ARI sold 7.32K, and BOUSBIB ARI sold 13.74K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for IQV?
Yes. Rallies tracks IQV insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is IQV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IQV. It does not provide personalized investment advice.
